Adriano Martinelli Selected Research

Multiple Sclerosis

3/2015	Application of a FLAP-consensus docking mixed strategy for the identification of new fatty acid amide hydrolase inhibitors.
12/2013	Immune-modulation and properties of absorption and blood brain barrier permeability of 1,8-naphthyridine derivatives.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adriano Martinelli Research Topics

Disease

22	Neoplasms (Cancer) 01/2022 - 11/2007
2	Amyloidosis 01/2016 - 01/2012
2	Multiple Sclerosis 03/2015 - 12/2013
2	Rheumatoid Arthritis 03/2015 - 10/2009
2	Glioma (Gliomas) 02/2015 - 01/2012
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2012 - 03/2008
1	Carcinoma (Carcinomatosis) 01/2022
1	Glaucoma 06/2018
1	Osteoporosis 06/2018
1	Hypersensitivity (Allergy) 01/2018
1	Neoplasm Metastasis (Metastasis) 09/2015
1	Neuralgia (Stump Neuralgia) 06/2015
1	Neuroinflammatory Diseases 03/2015
1	Lung Neoplasms (Lung Cancer) 12/2013
1	Nervous System Diseases (Neurological Disorders) 12/2013
1	Inflammation (Inflammations) 01/2012
1	Brain Injuries (Brain Injury) 01/2012
1	Alzheimer Disease (Alzheimer's Disease) 01/2012
1	Hypoxia (Hypoxemia) 03/2011
1	Starvation 03/2011
1	Emphysema 10/2009
1	Atherosclerosis 10/2009
1	Chronic Obstructive Pulmonary Disease (COPD) 10/2009
1	Osteoarthritis 08/2009
1	Liver Neoplasms (Liver Cancer) 02/2009
1	Asthma (Bronchial Asthma) 03/2008
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2007

Drug/Important Bio-Agent (IBA)

8	EnzymesIBA 01/2022 - 12/2008
5	Lactate Dehydrogenase 5IBA 01/2016 - 03/2011
4	Pharmaceutical PreparationsIBA 01/2022 - 03/2008
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2012
3	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 11/2013
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2015 - 11/2011
3	Protein Isoforms (Isoforms)IBA 11/2011 - 12/2008
2	LigandsIBA 01/2016 - 06/2012
2	Prealbumin (Transthyretin)IBA 01/2016 - 01/2012
2	Matrix Metalloproteinases (MMPs)IBA 09/2015 - 10/2009
2	Biological ProductsIBA 01/2015 - 08/2009
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2011 - 03/2011
2	Antineoplastic Agents (Antineoplastics)IBA 03/2011 - 02/2009
1	Histone Deacetylase InhibitorsIBA 01/2022
1	Anti-Infective Agents (Microbicides)IBA 01/2022
1	TubulinIBA 01/2022
1	Carbonic Anhydrase IIIBA 06/2018
1	ZincIBA 06/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018
1	Monoacylglycerol LipasesIBA 11/2016
1	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 06/2015
1	EndocannabinoidsIBA 03/2015
1	Estrogen ReceptorsIBA 02/2015
1	Mannose (D-Mannose)IBA 01/2015
1	SugarsIBA 01/2015
1	OximesIBA 12/2013
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 12/2013
1	CB2 Cannabinoid ReceptorIBA 12/2013
1	CannabinoidsIBA 12/2013
1	Proto-Oncogene Proteins c-fynIBA 10/2013
1	EstersIBA 10/2013
1	methyl 1- hydroxy- 6- phenyl- 4- (trifluoromethyl)- 1H- indole- 2- carboxylateIBA 10/2013
1	GABA-A Receptors (GABA(A) Receptor)IBA 01/2012
1	Pyruvic Acid (Pyruvate)IBA 11/2011
1	Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA 07/2011
1	Folic Acid (Vitamin M)FDA LinkGeneric 07/2011
1	Histone Deacetylases (Histone Deacetylase)IBA 07/2011
1	Methotrexate (Mexate)FDA LinkGeneric 07/2011
1	Pancreatic Elastase (Elastase)IBA 10/2009
1	Matrix Metalloproteinase 13IBA 08/2009
1	ErbB Receptors (EGF Receptor)IBA 02/2009
1	Adenosine (Adenocard)FDA LinkGeneric 03/2008
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 11/2007
1	Angiotensin IIIBA 01/2007

Therapy/Procedure

5	Therapeutics 01/2022 - 12/2008